Global Alcoholic Liver Diseases Treatment Market 2021 – 2031 Explore Future Growth With Top Players | Johnson & Johnson Services, Inc., Sanofi, Upsher-Smith Laboratories

Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring. Alcohol remains the most common cause of chronic diseases in the United States and other Western countries. The liver is one of the vital organs of the body, which performs various functions such as regulating cholesterol and blood sugar, filtering out blood toxins, and many others. The symptoms of alcoholic liver diseases generally develop in middle age between 30-40 years. The range of clinical features of alcoholic liver diseases varies widely from asymptomatic to end-stage liver diseases.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1393

The major symptoms of alcoholic liver diseases are portal hypertension, jaundice, abdominal pain, diarrhea, and many more. According to CDC (Centers for Disease Control and Prevention), the number of deaths from alcoholic liver diseases was 19,388 in the year 2014. Alcoholic liver diseases are one of the main reasons for liver transplantation. There are four main stages of alcoholic liver diseases – alcoholic fatty liver disease, alcoholic liver hepatitis, liver fibrosis, and liver cirrhosis. According to NHS (National Health Services), alcoholic liver diseases accounted for 82% of overall alcohol-specific deaths. Abstinence and lifestyle modifications, pharmacotherapy, nutritional supplements, and several other medications improve the survival rate in alcoholic cirrhotic patients.

Alcoholic Liver Diseases Treatment Market: Drivers and Restraints

Rapidly changing lifestyle pattern such as increasing alcohol consumption and unhealthy diets are the factors driving the alcoholic liver diseases treatment market. The increasing prevalence of liver diseases is also expected to boost the alcoholic liver diseases treatment market during the stated forecast period. Rising R&D funding by governments for the development of novel therapies to treat chronic liver diseases also escalates the market for alcoholic liver diseases treatment. The side effects associated with medications are expected to hamper the growth of the Alcoholic Liver Diseases Treatment market during the overall forecast period. Stringent government regulations for the approval of drugs also decline the growth of the alcoholic liver diseases treatment market. Lack of awareness and poor diagnosis facilities in the low economic regions also degrade the alcoholic liver diseases treatment market.

To receive extensive list of important regions, ask for TOC here – https://www.factmr.com/connectus/sample?flag=T&rep_id=1393

Alcoholic Liver Diseases Treatment Market: Segmentation

The global alcoholic liver diseases treatment market can be segmented on the basis of indication, treatment, distribution channel, and geography.

Based on indication, the global alcoholic liver diseases treatment market is segmented as:

• Alcoholic Fatty Liver Disease
• Alcoholic Liver Hepatitis
• Liver Fibrosis
• Liver Cirrhosis

Based on treatment, the global alcoholic liver diseases treatment market is segmented as:

• Pentoxifylline
• Glucocorticosteroids
  • Prednisone
  • Triamcinolone
  • Prednisolone
• Betaine
• Others

Based on distribution channel, the global alcoholic liver diseases treatment market is segmented as:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• Others

Pre-Book Right Now for Exclusive Analyst Support – https://www.factmr.com/checkout/1393/S

Alcoholic Liver Diseases Treatment Market: Key Players

Examples of some of the key players operating in the global alcoholic liver diseases treatment market are Johnson & Johnson Services, Inc., Sanofi, Upsher-Smith Laboratories, LLC, F. Hoffmann-La Roche AG, Novartis AG, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, and many others.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com